Ocugen said OCU400 is now available in the Bahamas for retinitis pigmentosa patients through a commercial Expanded Access Program. The move, backed by Bahamian health authorities, marks a step toward broader gene-therapy access worldwide.
published
Ocugen said OCU400 is now available in the Bahamas for retinitis pigmentosa patients through a commercial Expanded Access Program. The move, backed by Bahamian health authorities, marks a step toward broader gene-therapy access worldwide.
Latest documented BWB result
See Billy's timestamped results and follow-through.
Review the latest gains posts, original timestamps, and proof images published by Banking With Billy.
Historical results are not a promise of future performance. Trading involves substantial risk.This public post is a timestamped information archive, not personalized financial advice. Alerts can change as markets move. Join Billy's private group for the complete daily stream and follow-through.